OpenAI 收购了 Orchestra Bio，这是一家拥有四年历史的初创公司，专注于用于药物发现操作的 AI 代理。此次收购旨在加强 OpenAI 在生命科学领域的实力，将 Orchestra 的团队和技术整合到 OpenAI 的 Rosalind AI 模型和 Rosalind Workbench 工具中。此举标志着大型 AI 实验室将其软件产品扩展到制药等关键行业的更广泛趋势，可能使它们成为现有公司的竞争对手。 AI
影响 将 OpenAI 的业务扩展到制药行业，可能带来新的竞争格局。
排序理由 大型 AI 实验室收购初创公司以将其技术整合到现有产品中。
在 Mastodon — mastodon.social 阅读 →
AI 生成摘要 · Google Gemini · 来自 4 个来源。 我们如何撰写摘要 →
完整方法见我们的编辑标准。
OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.
Archaeologists Thought Malta’s Mysterious Stone ‘Railways’ Were Prehistoric. The Evidence Tells a Different Story Archaeologists have long contested the true origins of the numerous trails carved into the bedrocks of the Maltese archipelago. The answer may not be as mysterious as…
OpenAI acquires startup Orchestra Bio to beef up its biotech business OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan ex…
🤖 OpenAI acquires startup Orchestra Bio to beef up its biotech business OpenAI says it's adding Orchestra's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researc... 📰 Sour…